Delivery Order SPE2DE24DA017-SPE2D625F5338

Award Date 10/16/24
Potential Completion Date 10/21/24
Potential Value $2.5K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Fixed Price with Economic Price Adjustment
Place of Performance
Naples, FL 34108, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $2,475.00, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Arthrex Inc., a global leader in minimally invasive orthopedic products and procedures. The contract is for the delivery of the Arthrex ACP Double Syringe System, a specialized medical device used in orthopedic procedures. The contract has an ultimate completion date of January 8, 2025 and is a Delivery Order with a Fixed Price with Economic Price...
This federal contract award was made by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Arthrex Inc., a global leader in minimally invasive orthopedic products and procedures. The $3,939.62 fixed-price delivery order is for the Arthrex ACP Double Syringe System, which will be delivered by November 22, 2024. Arthrex, a for-profit Subchapter S Corporation, has a significant single-award Indefinite Delivery Contract (IDC) valued at $471,048,172.66 with the DLA that allows...
This federal contract award was issued by the Defense Logistics Agency's (DLA) Medical Supply Chain to Arthrex Inc., a global leader in minimally invasive orthopedic products and procedures. The $1,650.00 fixed-price with economic price adjustment delivery order is for the Arthrex ACP Double Syringe System, a specialized medical device used for orthopedic procedures. The contract has an ultimate completion date of December 27, 2024. Arthrex, a for-profit Subchapter S Corporation headquartered in...
The federal contract award is for the Arthrex ACP Double Syringe System, awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Arthrex Inc., a global leader in minimally invasive orthopedic products and procedures. The fixed-price contract with economic price adjustment has a ceiling value of $5,254.92 and an ultimate completion date of October 23, 2024. Arthrex, a for-profit Subchapter S Corporation, has a significant single-award Indefinite Delivery Contract...
This federal contract award is for the Arthrex ACP Double Syringe System, awarded by the Defense Logistics Agency's Medical Supply Chain to Arthrex Inc., a global leader in minimally invasive orthopedic products and procedures. The fixed-price delivery order, valued at $1,650.00, has an ultimate completion date of November 8, 2024. Arthrex, a for-profit Subchapter S Corporation, has a significant Indefinite Delivery Contract (IDC) with the Defense Logistics Agency, valued at $471,048,172.66...
This is a federal contract award to Arthrex Inc., a global leader in minimally invasive orthopedic products and procedures. The contract, awarded by the Defense Logistics Agency's (DLA) Medical Supply Chain, is for the provision of the ARTHREX ACP DOUBLE SYRINGE SYSTEM, a specialized medical device. The contract has a fixed price with economic price adjustment pricing type, a ceiling value of $1,650.00, and a period of performance ending on January 10, 2025. The contract is not designated as a...
This federal contract award from the Defense Logistics Agency's Medical Supply Chain was issued to Arthrex Inc., a global leader in minimally invasive orthopedic products and procedures. The contract, valued at $2,475.00, is for the delivery of the Arthrex ACP Double Syringe System, a specialized medical device used in orthopedic procedures. The contract is a Delivery Order with a fixed price and economic price adjustment pricing type, with an ultimate completion date of December 9, 2024....
This federal contract award, valued at $9,435.39, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Arthrex Inc., a global leader in minimally invasive orthopedic products and procedures. The contract is a Delivery Order for the supply of various orthopedic medical products, including surgical implants, arthroscopic instruments, and specialized medical devices. Arthrex, a for-profit Subchapter S Corporation, has a significant Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency's Medical Supply Chain to Arthrex Inc., a global leader in minimally invasive orthopedic products and procedures. The contract is for the delivery of an Arthrex ACP Double Syringe System, a specialized medical device used in orthopedic procedures. The contract has a fixed price with economic price adjustment, a ceiling value of $3,300.00, and runs through November 15, 2024. This order is part of a larger Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency's (DLA) Medical Supply Chain to Arthrex Inc., a global leader in minimally invasive orthopedic medical technologies. The contract is for the delivery of the ARTHREX ACP DOUBLE SYRINGE SYSTEM, a specialized medical device, with a ceiling value of $4,950. The contract is a Delivery Order with a Fixed Price with Economic Price Adjustment pricing type, and has an ultimate completion date of January 21, 2025. Arthrex Inc. is a...
  • SPE2DE24DA017
    Indefinite Delivery Contract
  • SPE2DE24DA017-SPE2D625F5338
    Delivery Order

This federal contract award, valued at $2,475.00, was issued by the Medical Supply Chain of the Defense Logistics Agency (DLA) to Arthrex Inc., a global leader in minimally invasive orthopedic products and procedures. The contract is for the provision of Arthrex's ACP Double Syringe System, a specialized medical device used in orthopedic procedures. The contract is a Delivery Order with a Fixed Price with Economic Price Adjustment pricing type and has an ultimate completion date of October 21, 2024. Arthrex, a for-profit Subchapter S Corporation, has a significant Indefinite Delivery Contract (IDC) with the DLA valued at $471,048,172.66, which allows VA medical centers to acquire a wide range of Arthrex's innovative orthopedic technologies through task orders. The contract award does not have a set-aside designation, indicating Arthrex's strong competitive position in the federal market for orthopedic medical products and solutions.

Generated 1/15/25, 9:33 AM